Entero Therapeutics Inc expected to post a loss of $1.55 a share - Earnings Preview

Reuters · 08/30 20:10
Entero Therapeutics Inc <ENTO.OQ> expected to post a loss of $1.55 a share - Earnings Preview
  • Entero Therapeutics Inc ENTO.OQ ENTO.O is expected to show change in quarterly revenue when it reports results on September 2 (estimated) for the period ending June 30 2024


  • ​LSEG's mean analyst estimate for Entero Therapeutics Inc is for a loss of $1.55 per share.

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and "sell" or "strong sell."

  • The mean earnings estimate of analysts was unchanged in the last three months. ​

  • Wall Street's median 12-month price target for Entero Therapeutics Inc is $36.00​, above​ its last closing price of $0.42. ​​​

This summary was machine generated August 30 at 20:10 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)